Finance

Lists
Why is METROPOLIS down 2,22%?
Dive Deeper
METROPOLIS:NSE
Metropolis Healthcare Ltd
522,90 INR
-2,22%
(-11,85) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for METROPOLIS...
Open
531,00 INR
High
533,25 INR
Low
519,40 INR
Mkt. cap
108,48 მლრ.
Avg. vol.
234,40 ათ.
Volume
369,68 ათ.
Dividend
0,57%
Quarterly dividend
0,75 INR
Ex-dividend date
19 მაი. 2026
P/E ratio
53,85
52-wk high
609,05 INR
52-wk low
412,25 INR
EPS
9,71 INR
No. of employees
4 ათ.
Open
531,00 INR
High
533,25 INR
Low
519,40 INR
Mkt. cap
108,48 მლრ.
Avg. vol.
234,40 ათ.
Volume
369,68 ათ.
Dividend
0,57%
Quarterly dividend
0,75 INR
Ex-dividend date
19 მაი. 2026
P/E ratio
53,85
52-wk high
609,05 INR
52-wk low
412,25 INR
EPS
9,71 INR
No. of employees
4 ათ.
News stories
From web sources and news partners
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOვიენდერ სინგ
Employees4,48 ათ.
Founded1980
Headquarters-
SectorHealth care provider
Websitemetropolisindia.com
Last report
5 აგვ. 2026
Fiscal period
Q1 2027
2,73 INR / 2,65 INR
+3,07%beat
Revenue / Est. (INR)
4,50 მლრდ. / 4,46 მლრდ.
+0,93%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,29 მლრდ.
4,06 მლრდ.
4,25 მლრდ.
4,50 მლრდ.
Cost of goods sold
877,48 მლნ.
792,37 მლნ.
1,27 მლრდ.
871,01 მლნ.
Cost of revenue
877,48 მლნ.
792,37 მლნ.
1,27 მლრდ.
871,01 მლნ.
Research and development expenses
49,67 მლნ.
80,57 მლნ.
43,07 მლნ.
63,30 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
953,93 მლნ.
942,25 მლნ.
2,92 მლრდ.
1,07 მლრდ.
Operating expense
2,66 მლრდ.
2,64 მლრდ.
2,28 მლრდ.
2,84 მლრდ.
Total operating expenses
3,53 მლრდ.
3,43 მლრდ.
3,55 მლრდ.
3,71 მლრდ.
Operating income
758,17 მლნ.
629,68 მლნ.
701,16 მლნ.
787,90 მლნ.
Other non operating income
8,91 მლნ.
90,16 მლნ.
-64,72 მლნ.
51,02 მლნ.
EBT including unusual items
710,26 მლნ.
571,57 მლნ.
697,63 მლნ.
777,12 მლნ.
EBT excluding unusual items
710,26 მლნ.
662,53 მლნ.
663,07 მლნ.
777,12 მლნ.
Income tax expense
181,36 მლნ.
150,70 მლნ.
188,03 მლნ.
208,29 მლნ.
Effective tax rate
25,53%
26,37%
26,95%
26,80%
Other operating expenses
1,33 მლრდ.
1,30 მლრდ.
-1,07 მლრდ.
1,39 მლრდ.
Net income
526,68 მლნ.
413,86 მლნ.
509,03 მლნ.
566,67 მლნ.
Net profit margin
12,27%
10,20%
11,99%
12,59%
Earnings per share
2,53
2,31
2,46
2,73
Interest and investment income
-
-
38,12 მლნ.
-
Interest expense
-56,82 მლნ.
-57,30 მლნ.
-79,33 მლნ.
-61,80 მლნ.
Net interest expenses
-56,82 მლნ.
-57,30 მლნ.
-41,21 მლნ.
-61,80 მლნ.
Depreciation and amortization charges
324,08 მლნ.
318,78 მლნ.
385,90 მლნ.
324,03 მლნ.
EBITDA
1,07 მლრდ.
680,74 მლნ.
774,79 მლნ.
861,53 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები